Literature DB >> 15683448

Influence on spontaneous tissue inflammation by the major histocompatibility complex region in the nonobese diabetic mouse.

A-K B Lindqvist1, B Nakken, M Sundler, P Kjellén, R Jonsson, R Holmdahl, K Skarstein.   

Abstract

We investigated the role of the major histocompatibility complex (MHC) region in the specificity of autoimmunity by analysing specifically the development of sialadenitis, but also insulitis, nephritis and autoantibody production in autoimmune-prone nonobese diabetic (NOD) mice where the MHC H2g7 haplotype had been exchanged for the H2q (NOD.Q) or H2p (NOD.P) haplotype. The exchange of H2 haplotype did not affect the frequency of sialadenitis because the H2q and H2p congenic NOD strains developed sialadenitis with the same incidence as NOD. However, the severity of sialadenitis varied among the strains, as NOD.Q >NOD >NOD.P. At 11-13 weeks of age, the NOD.Q (H2q) female mice developed more severe sialadenitis compared to NOD.P (H2p) (P=0.038). At 20 weeks, the NOD (H2g7) female mice showed more severe sialadenitis than NOD.P (P=0.049). This is in contrast to the development of insulitis in the present strains, because the incidence of insulitis was almost completely inhibited by the replacement of the H2g7 haplotype of NOD. The incidence of insulitis in NOD.Q was 11-22%, compared to 75% in NOD, which correlated well with lower titres of anti-glutamic acid decarboxylase (anti-GAD) antibodies in NOD.Q compared to NOD (P=0.009). However, the introduction of the H2q haplotype into the NOD strain instead directed the autoimmune response towards the production of lupus types of autoantibodies, because the incidence of antinuclear antibodies (ANA) in NOD.Q was 89% compared with 11% in NOD.P and 12% in NOD mice, which in turn correlated with a high incidence of nephritis in NOD.Q compared to NOD. Consequently, we show that different haplotypes of MHC are instrumental in directing the specificity of the spontaneous autoimmune inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15683448     DOI: 10.1111/j.0300-9475.2005.01550.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

Review 1.  Animal models of Sjögren's syndrome.

Authors:  Malin V Jonsson; Nicolas Delaleu; Roland Jonsson
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 2.  What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome?

Authors:  Ammon B Peck; Cuong Q Nguyen
Journal:  Clin Immunol       Date:  2017-05-03       Impact factor: 3.969

3.  Supra-lacrimal protein-based carriers for cyclosporine A reduce Th17-mediated autoimmunity in murine model of Sjögren's syndrome.

Authors:  Hao Guo; Yaping Ju; Minchang Choi; Maria C Edman; Stan G Louie; Sarah F Hamm-Alvarez; J Andrew MacKay
Journal:  Biomaterials       Date:  2022-02-26       Impact factor: 12.479

4.  A novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndrome.

Authors:  Hao Guo; Changrim Lee; Mihir Shah; Srikanth R Janga; Maria C Edman; Wannita Klinngam; Sarah F Hamm-Alvarez; J Andrew MacKay
Journal:  J Control Release       Date:  2018-10-23       Impact factor: 9.776

Review 5.  Sjögren's syndrome: studying the disease in mice.

Authors:  Nicolas Delaleu; Cuong Q Nguyen; Ammon B Peck; Roland Jonsson
Journal:  Arthritis Res Ther       Date:  2011-06-13       Impact factor: 5.156

Review 6.  The clinical relevance of animal models in Sjögren's syndrome: the interferon signature from mouse to man.

Authors:  Naomi I Maria; Petra Vogelsang; Marjan A Versnel
Journal:  Arthritis Res Ther       Date:  2015-07-03       Impact factor: 5.156

7.  Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.

Authors:  Joanna Kern; Robert Drutel; Silvia Leanhart; Marek Bogacz; Rafal Pacholczyk
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

8.  Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.

Authors:  Mihir Shah; Maria C Edman; Srikanth Reddy Janga; Frances Yarber; Zhen Meng; Wannita Klinngam; Jonathan Bushman; Tao Ma; Siyu Liu; Stan Louie; Arjun Mehta; Chuanqing Ding; J Andrew MacKay; Sarah F Hamm-Alvarez
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

9.  The Spontaneous Autoimmune Neuromyopathy in ICOSL-/- NOD Mice Is CD4+ T-Cell and Interferon-γ Dependent.

Authors:  Claire Briet; Gwladys Bourdenet; Ute C Rogner; Chantal Becourt; Isabelle Tardivel; Laurent Drouot; Christophe Arnoult; Jean-Claude do Rego; Nicolas Prevot; Charbel Massaad; Olivier Boyer; Christian Boitard
Journal:  Front Immunol       Date:  2017-03-31       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.